These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 31094048)
1. A theoretical exploration of therapeutic monomania as a physician-based instrumental variable. Potter BJ; Dormuth C; Le Lorier J Pharmacoepidemiol Drug Saf; 2020 Jan; 29 Suppl 1(Suppl 1):45-52. PubMed ID: 31094048 [TBL] [Abstract][Full Text] [Related]
2. Instrumental variable applications using nursing home prescribing preferences in comparative effectiveness research. Huybrechts KF; Gerhard T; Franklin JM; Levin R; Crystal S; Schneeweiss S Pharmacoepidemiol Drug Saf; 2014 Aug; 23(8):830-8. PubMed ID: 24664805 [TBL] [Abstract][Full Text] [Related]
3. Power calculator for instrumental variable analysis in pharmacoepidemiology. Walker VM; Davies NM; Windmeijer F; Burgess S; Martin RM Int J Epidemiol; 2017 Oct; 46(5):1627-1632. PubMed ID: 28575313 [TBL] [Abstract][Full Text] [Related]
4. Instrumental variable analysis in the context of dichotomous outcome and exposure with a numerical experiment in pharmacoepidemiology. Koladjo BF; Escolano S; Tubert-Bitter P BMC Med Res Methodol; 2018 Jun; 18(1):61. PubMed ID: 29929467 [TBL] [Abstract][Full Text] [Related]
5. Instrumental variables II: instrumental variable application-in 25 variations, the physician prescribing preference generally was strong and reduced covariate imbalance. Rassen JA; Brookhart MA; Glynn RJ; Mittleman MA; Schneeweiss S J Clin Epidemiol; 2009 Dec; 62(12):1233-41. PubMed ID: 19345561 [TBL] [Abstract][Full Text] [Related]
6. Evaluating the validity of an instrumental variable study of neuroleptics: can between-physician differences in prescribing patterns be used to estimate treatment effects? Brookhart MA; Rassen JA; Wang PS; Dormuth C; Mogun H; Schneeweiss S Med Care; 2007 Oct; 45(10 Supl 2):S116-22. PubMed ID: 17909369 [TBL] [Abstract][Full Text] [Related]
7. Evaluating different physician's prescribing preference based instrumental variables in two primary care databases: a study of inhaled long-acting beta2-agonist use and the risk of myocardial infarction. Uddin MJ; Groenwold RH; de Boer A; Afonso AS; Primatesta P; Becker C; Belitser SV; Hoes AW; Roes KC; Klungel OH Pharmacoepidemiol Drug Saf; 2016 Mar; 25 Suppl 1():132-41. PubMed ID: 27038359 [TBL] [Abstract][Full Text] [Related]
8. Evaluating possible confounding by prescriber in comparative effectiveness research. Franklin JM; Schneeweiss S; Huybrechts KF; Glynn RJ Epidemiology; 2015 Mar; 26(2):238-41. PubMed ID: 25643103 [TBL] [Abstract][Full Text] [Related]
9. Instantaneous preference was a stronger instrumental variable than 3- and 6-month prescribing preference for NSAIDs. Hennessy S; Leonard CE; Palumbo CM; Shi X; Ten Have TR J Clin Epidemiol; 2008 Dec; 61(12):1285-1288. PubMed ID: 18495427 [TBL] [Abstract][Full Text] [Related]
10. Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable. Brookhart MA; Wang PS; Solomon DH; Schneeweiss S Epidemiology; 2006 May; 17(3):268-75. PubMed ID: 16617275 [TBL] [Abstract][Full Text] [Related]
11. Comparing the performance of two-stage residual inclusion methods when using physician's prescribing preference as an instrumental variable: unmeasured confounding and noncollapsibility. Zhang L; Lewsey J J Comp Eff Res; 2024 May; 13(5):e230085. PubMed ID: 38567965 [No Abstract] [Full Text] [Related]
12. Falsification Tests for Instrumental Variable Designs With an Application to Tendency to Operate. Keele L; Zhao Q; Kelz RR; Small D Med Care; 2019 Feb; 57(2):167-171. PubMed ID: 30520835 [TBL] [Abstract][Full Text] [Related]
13. Definition and evaluation of the monotonicity condition for preference-based instruments. Swanson SA; Miller M; Robins JM; Hernán MA Epidemiology; 2015 May; 26(3):414-20. PubMed ID: 25782755 [TBL] [Abstract][Full Text] [Related]
14. Assessing the performance of physician's prescribing preference as an instrumental variable in comparative effectiveness research with moderate and small sample sizes: a simulation study. Zhang L; Lewsey J; McAllister DA J Comp Eff Res; 2024 May; 13(5):e230044. PubMed ID: 38567966 [No Abstract] [Full Text] [Related]
15. Bias-variance trade-off in pharmacoepidemiological studies using physician-preference-based instrumental variables: a simulation study. Ionescu-Ittu R; Delaney JA; Abrahamowicz M Pharmacoepidemiol Drug Saf; 2009 Jul; 18(7):562-71. PubMed ID: 19437424 [TBL] [Abstract][Full Text] [Related]
16. Benzodiazepine prescribing for children, adolescents, and young adults from 2006 through 2013: A total population register-linkage study. Sidorchuk A; Isomura K; Molero Y; Hellner C; Lichtenstein P; Chang Z; Franck J; Fernández de la Cruz L; Mataix-Cols D PLoS Med; 2018 Aug; 15(8):e1002635. PubMed ID: 30086134 [TBL] [Abstract][Full Text] [Related]
17. Variability in emergency physician decision making about prescribing opioid analgesics. Tamayo-Sarver JH; Dawson NV; Cydulka RK; Wigton RS; Baker DW Ann Emerg Med; 2004 Apr; 43(4):483-93. PubMed ID: 15039692 [TBL] [Abstract][Full Text] [Related]
18. Childhood Attention-Deficit/Hyperactivity Disorder Prescribing by Prescriber Type and Specialty in Oregon Medicaid. Klein TA; Panther S; Woo T; Odom-Maryon T; Daratha K J Child Adolesc Psychopharmacol; 2016 Aug; 26(6):548-54. PubMed ID: 27135134 [TBL] [Abstract][Full Text] [Related]
19. Pharmaceutical payments to physicians may increase prescribing for opioids. Nguyen TD; Bradford WD; Simon KI Addiction; 2019 Jun; 114(6):1051-1059. PubMed ID: 30667135 [TBL] [Abstract][Full Text] [Related]
20. Development of an indicator to identify inappropriate use of benzodiazepines in elderly medical in-patients. Batty GM; Oborne CA; Swift CG; Jackson SH Int J Geriatr Psychiatry; 2000 Oct; 15(10):892-6. PubMed ID: 11044870 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]